Centro de Investigacion Clinica Chapultepec S.A. de C.V.

Morelia, Michoacán 58260

1 studies enrolling now · 4 studies all time

What they study most

Metastatic Renal Cell Carcinoma, Pediatric Gastroesophageal Reflux Disease, Primary IgA Nephropathy, Relapsing-remitting Multiple Sclerosis, Renal Cell Carcinoma

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression — Recruiting now
• A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-remitting Multiple Sclerosis (RRMS) — Running, not enrolling
• A Study of Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC) — Stopped early
• Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months — Withdrawn before enrolling